What is it about?
Peripheral Artery Disease, Metabolic Syndrome and Endovascular Procedures
Featured Image
Why is it important?
Peripheral arterial disease (PAD) has a great morbidity, it is estimated that PAD prevalence is 10% of the population and rising to 15-20% in people over 70 years of age. PAD causes a reduction in the blood supply and generally begins as claudication or develop into a more serious condition as critical ischemia. Critical limb ischemia (CLI) can lead to tissue loss or amputation and patient are high risk of death. We will address the role of MetS in PAD and Endovascular Procedures (EP). In this brief communication we will discuss the relationship between MetS, PAD and EP.
Perspectives
Endovascular Procedures in the past decades have been used as option for PAD in those patients that evolve without improvement with clinical treatment, is a security alternative to open surgery when there are multiple comorbidities. Endovascular techniques are a good alternative when clinical treatment fails to improve quality of life without pain. Generally this includes intensive treatment of cardiovascular risk factors to prevent myocardial infarction and stroke in the postoperative period, which are related causes of death
Professor Paulo Eduardo Ocke Reis
Universidade Federal Fluminense
Read the Original
This page is a summary of: Peripheral Artery Disease, Metabolic Syndrome and Endovascular Procedures, Journal of Vascular and Endovascular Surgery, January 2017, Scitechnol Biosoft Pvt. Ltd.,
DOI: 10.21767/2573-4482.100068.
You can read the full text:
Contributors
The following have contributed to this page
